According to the new market research report "In Vitro Diagnostics Quality Control Market by Source (Plasma, Whole Blood, Urine), Technology (Immunoassay, Hematology, Microbiology, Molecular Diagnostics), Manufacturer (Third-party, OEM), End Users (Hospitals, Lab) - Global Forecast to 2026", published by MarketsandMarkets™, the global IVD Quality Control Market is projected to reach USD 1.4 billion by 2026 from USD 1.1 billion in 2021, at a CAGR of 5.3% during the forecast period.
Browse in-depth TOC on "In Vitro Diagnostics Quality Control Market"
252 – Tables
59 – Figures
342 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198032582
The IVD testing plays a significant role in clinical decision-making. Over the years, IVD quality control products and procedures have become mandatory in accredited clinical or medical laboratories. The applications of IVD quality control products have also widened over the years, with a number of quality controls currently available in the market for clinical chemistry, immunochemistry, hematology, molecular diagnostics, coagulation, and microbiology. To ensure technological competitiveness, companies are continuously launching innovative and advanced quality control products in the market for a variety of applications.
The growth of the Quality Control in IVD Market is primarily driven by the rising number of accredited clinical laboratories, rising geriatric population, rising demand for external quality assessment programs, increasing adoption of and POC instruments in developed regions and increasing adoption of third-party quality controls. The rising focus on multi-analyte controls is also expected to offer significant growth opportunities for the market in the coming years. The use of quality control products is, however, not mandatory for all clinical laboratories in many countries. The lack of regulations for these products is expected to adversely affect market growth.
The product & service segment holds the highest share of the total IVD quality control market during the forecast period.
Based on product & service, the IVD Quality Control Market is segmented into quality control products, data management solutions, and quality assurance services. The quality control products segment accounted for the largest share of the market in 2020. The increasing number of accredited laboratories and mandates for the use of quality controls from regulatory bodies to ensure the accuracy of diagnostic test results are driving the growth of the IVD quality control products market.
Immunochemistry accounted for the highest share of the technology segment of the global IVD quality control market
Based on technology, the IVD Quality Control Market is broadly segmented into clinical chemistry, immunochemistry, hematology, coagulation & hemostasis, microbiology, molecular diagnostics, and other technologies. The immunochemistry segment accounted for the largest share of the market in 2020. The large share of this segment can be attributed to the increasing use of multi-analyte controls to perform immunoassay tests in laboratories. The use of immunoassay tests in clinical laboratories has also increased due to the high sensitivity of these tests over conventional methods.
Third-party controls accounted for the largest share for the IVD quality control market
Based on manufacturer, the In Vitro Diagnostics Quality Control Market is segmented into third-party controls and OEM controls. The third-party controls segment accounted for the largest share of the global market in 2020. The large share of this segment can be attributed to the increasing use of third-party quality controls across the globe to verify the accuracy and reliability of tests
Hospitals accounted for the highest share of the global IVD quality control market
The key end users of IVD quality controls studied in this report include hospitals, clinical laboratories, research & academic institutes, and other end users. The hospitals segment accounted for the largest share of the market in 2020, owing to the large volume of diagnostic tests carried out in hospitals.
North America is expected to account for the largest share for players operating in the global IVD quality control market
Geographically, the global In Vitro Diagnostics Quality Control Market studied in this report is divided into five major regions— North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the global market, followed by Europe. Recommendations for and approvals of quality control products from the FDA and the College of American Pathologists (CAP) and the presence of well-established distribution channels and leading companies in the US are driving the market in North America.
Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=198032582
Some of the key players in the In Vitro Diagnostics (IVD) Quality Control Market include Bio-Rad Laboratories, Inc. (US), Randox Laboratories Ltd. (UK), Thermo Fisher Scientific, Inc. (US), LGC Limited (UK), and Abbott Laboratories (US). Other prominent payers in the market include Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Fortress Diagnostics (UK), SERO AS (US), Sysmex Corporation (Japan), Ortho-Clinical Diagnostics (US), Helena Laboratories Corporation (US), Quidel Corporation (US), Sun Diagnostics, LLC (US), Seegene Inc. (South Korea), ZeptoMetrix Corporation (US), Qnostics (UK), Bio-Techne Corporation (US), Microbiologics (US), Microbix Biosystems (Canada), Streck, Inc. (US), Alpha-Tec Systems (US), Maine Molecular Quality Controls, Inc. (US), and Grifols, S.A. (Spain). These players aim to secure higher market shares through strategies such as product launches, expansions, agreements, and acquisitions.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Content Source: https://www.marketsandmarkets.com/PressReleases/in-vitro-diagnostics-quality-controls.asp
In Vitro Diagnostics Quality Control Market worth $1.4 billion by 2026
11 February 2020 - The global In Vitro Diagnostics (IVD) Quality Control Market is anticipated to reach USD 1.13 billion by 2024.
The rising number of certified clinical laboratories requires quality control (QC) services to maintain their standards, associated with the increasing acceptance of third party providers of quality control services, to ensure the accurate and reproducible test results, and better outcomes which is anticipated to drive the growth.For the establishment of definite standards of quality, the internal Quality Control (QC) programs and the external QAS (Quality Assurance Schemes) is very important to ensure validity and reliability of the test results obtained by the IVD devices.
These programs are essential in confirming the delivery of patient diagnostic outcomes, which are reliable and without errors, such as misdiagnosis because of device-related errors, which can impact the health of the patient.Request a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/in-vitro-diagnostics-ivd-quality-control-marketThe regulation of these In vitro diagnostics devices are controlled by the respective regulatory bodies, which includes the U.S. FDA (Food and Drug Administration), the International Medical Device Regulators Forum (IMDRF), the European Commission, the Australian Therapeutic Goods Administration (TGA), the Eurasian Economic Union (EEU) and the Brazilian National Health Surveillance Agency (ANVISA).The currently undergoing, extensive R related activities beside the introduction of new laws with the aim of improving the efficacy and safety levels of the IVD services are anticipated to drive market growth.
For example, in September 2012, a new regulation for IVD devices was published by the European Commission targeted to enhance the transparency, safety and the traceability without constraining innovation.
In 2016, QC market was one of the largest segments because of the rapidly developing IVD technologies and the existence of numerous internal QC programs for the different features of the IVD device-based procedures of testingApplication InsightsThere are numerous applications of the IVDs, which includes haematology, immunology, coagulation, clinical chemistry, molecular diagnostics and microbiology.
The home care market segment is anticipated to observe a lucrative progression owing to the persistent increase in the usage devices for point-of-care testing.
This analysis of the Global In-Vitro Diagnostics (IVD) Quality Control Market aims to offer relevant and well-researched insights into the contemporary market scenario and the emergent growth dynamics.
The report on In-Vitro Diagnostics (IVD) Quality Control Market also gives the market players and fresh contenders a holistic view of the global market landscape.
The comprehensive study will help both established and emerging players formulate lucrative business strategies and realize their short-term and long-term goals.The In-Vitro Diagnostics (IVD) Quality Control industry has witnessed a stable growth rate in the past decade and is expected to continue on the same path in the forthcoming decades.
Therefore, it is crucial to recognize all investment opportunities, potential market threats, restraining factors, challenges, market dynamics, and technological development to intensify footholds in the In-Vitro Diagnostics (IVD) Quality Control sector.
This report has evaluated all the above mentioned aspects to present a detailed assessment to the reader to assist them in achieving the desired growth in their businesses.Fill in your details to get your hands on an Exclusive Sample of this Report @ https://www.reportsanddata.com/sample-enquiry-form/1508Companies profiled for this market studyAgilent Diagnostics, Abbott Diagnostics, Becton, Dickson and Company, Bio-Rad Laboratories, Inc., and ThermoFisher ScientificFor the purpose of the study, this Reports and Data has segmented the Global In-Vitro Diagnostics (IVD) Quality Control Market on the basis of product type, manufacturer type, design, application, end user and the regional outlook:Product Type (Revenue, USD Million; 2016–2026)Quality ControlsWhole Blood-based ControlsSerum-based ControlsPlasma-based ControlsUrine-based ControlsOther IVD Quality ControlsData Management SolutionsQuality Assurance ServicesManufacturer Type (Revenue, USD Million; 2016–2026)Instrument Manufacturer ControlsIndependent Manufacturer ControlsThird-party ControlsInstrument Specific Manufacturer ControlsApplication (Revenue, USD Million; 2016–2026)Clinical ChemistryImmunochemistryHaematologyMolecular DiagnosticsCoagulation/HaemostasisMicrobiologyOthersEnd User (Revenue, USD Million; 2016–2026)HospitalsClinical LaboratoriesHome CareOthersClick here to Get customization & check available discount for the report @ https://www.reportsanddata.com/discount-enquiry-form/1508Table of Contents:Study Coverage: It includes key manufacturers covered, key market segments, the scope of products offered in the global In-Vitro Diagnostics (IVD) Quality Control market, duration considered, and objectives of the research.
Additionally, it segments the market on the basis of product type and application.Executive Summary: It offers a summary of other key studies, annual growth rate, competitive landscape, driving factors, market trends and issues, and macroscopic indicators.Production by Region: Here, the report delivers information related to import and export, production, revenue, and key players of all regional markets inspected in the report.Profile of Manufacturers: Each firm profiled in this segment is investigated by means of SWOT analysis, available products, global production, value, capacity, and other crucial factors.Highlights the following key factors:1) Business description-Detailed description of a firm’s operations and business segments.2) Corporate strategy – Analyst’s summarization of the company’s business strategy.3) SWOT Analysis – A detailed analysis of the company’s strengths, weaknesses, opportunities, and challenges.4) Company history – A company’s evolution, highlighting its key events through the years.5) Major products and services – A list of flagship products, services, and brands of the company.6) Key competitors – A list of key competitors of the company.7) Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.8) Detailed financial ratios for the past five years – The latest financial ratios derived from annual financial statements released by the company in the last five years.Browse the comprehensive TOC and data tables @ https://www.reportsanddata.com/report-detail/in-vitro-diagnostics-ivd-quality-control-marketThe growth of this market across the globe is dependent on multiple factors; including consumer base of several In-Vitro Diagnostics (IVD) Quality Control products, inorganic growth models adopted by companies, price volatility of feedstocks, and product innovation, along with their economic prospects in both producer and consumer nations.Overall, this report provides a clear view of every vital factor of the market without the need to refer to any other research reports or data sources.
The rising number of certified clinical laboratories requires quality control (QC) services to maintain their standards, associated with the increasing acceptance of third party providers of quality control services, to ensure the accurate and reproducible test results, and better outcomes which is anticipated to drive the growth.
Request a Sample PDF Copy of This Report @ https://www.millioninsights.com/industry-reports/in-vitro-diagnostics-ivd-quality-control-market/request-sample The key driving factors responsible for the growth of In Vitro Diagnostics (IVD) Quality Control market : For the establishment of definite standards of quality, the internal Quality Control (QC) programs and the external QAS (Quality Assurance Schemes) is very important to ensure validity and reliability of the test results obtained by the IVD devices.
These programs are essential in confirming the delivery of patient diagnostic outcomes, which are reliable and without errors, such as misdiagnosis because of device-related errors, which can impact the health of the patient.
The regulation of these In vitro diagnostics devices are controlled by the respective regulatory bodies, which includes the U.S. FDA (Food and Drug Administration), the International Medical Device Regulators Forum (IMDRF), the European Commission, the Australian Therapeutic Goods Administration (TGA), the Eurasian Economic Union (EEU) and the Brazilian National Health Surveillance Agency (ANVISA).
The currently undergoing, extensive R related activities beside the introduction of new laws with the aim of improving the efficacy and safety levels of the IVD services are anticipated to drive market growth.
For example, in September 2012, a new regulation for IVD devices was published by the European Commission targeted to enhance the transparency, safety and the traceability without constraining innovation.
Global In-Vitro Diagnostics (IVD) Quality Control Market Forecast to 2028 encompasses crucial data about the global In-Vitro Diagnostics (IVD) Quality Control market and includes a thorough examination of technological development, market drivers, market share, market size, and regional segmentation.
The report also provides a comprehensive evaluation of the market trends, vital statistical data, accurate market estimations, and the key suppliers and manufacturers of the In-Vitro Diagnostics (IVD) Quality Control market.The report is also attuned with the currently ongoing COVID-19 pandemic and its effect on the key segments of the market.
The report is updated with the impact of COVID-19 crisis, economic landscape, and present and future impact of COVID-19 on the market.
The report also aims to benefit the user by providing constructive data to gain insight into the market growth, size, and investment approaches.The key companies profiled in the market are: Abbott Laboratories Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Siemens Healthineers, Randox Laboratories Ltd., Technopath Clinical Diagnostics, Fortress Diagnostics, Roche Diagnostics, Bio-Techne Corporation, Danaher Corporation, SeraCare Life Sciences Inc.The report also covers a comprehensive analysis of the strategic alliances such as mergers and acquisitions, joint ventures, partnerships, collaborations, agreements, government and corporate deals, and product launches and brand promotions.
The report also offers a thorough analysis of the product portfolios, production capacity, gross margins, revenues, and costing of the key manufacturers and vendors.
Furthermore, it also covers SWOT analysis and Porter’s Five Forces Analysis to offer a deeper insight into the competitive landscape of the market.By Product & Service Type (Revenue, USD Million; 2018-2028)Quality Control ProductsWhole Blood-based ControlsSerum/Plasma-based ControlsUrine-based ControlsData Management SolutionsQuality Assurance ServicesSource-based IVD Quality ControlsBy Manufacturer (Revenue, USD Million; 2018-2028)Third-Party Control ManufacturersOriginal Equipment Manufacturers (OEMs)Instrument-Specific ControlsIndependent ControlsBy Application (Revenue, USD Million; 2018-2028)Immunochemistry/ImmunoassayCoagulation & HemostasisMolecular DiagnosticsClinical ChemistryMicrobiologyHematologyOthersBy End-user (Revenue, USD Million; 2018-2028)HospitalsHome CareClinical LaboratoriesAcademic & Research InstitutesContract Research Organizations (CROs)IVD ManufacturersOthersBrowse Complete Report “In-Vitro Diagnostics (IVD) Quality Control Market” @ https://www.reportsanddata.com/report-detail/in-vitro-diagnostics-ivd-quality-control-marketThe report further segments the market on the basis of key regions of the world and offers an assessment of the production and manufacturing capacity, import and export, production and consumption patterns, supply and demand ratio, and the presence of key players in each region.
11 February 2020 - The global In Vitro Diagnostics (IVD) Quality Control Market is anticipated to reach USD 1.13 billion by 2024.
The rising number of certified clinical laboratories requires quality control (QC) services to maintain their standards, associated with the increasing acceptance of third party providers of quality control services, to ensure the accurate and reproducible test results, and better outcomes which is anticipated to drive the growth.For the establishment of definite standards of quality, the internal Quality Control (QC) programs and the external QAS (Quality Assurance Schemes) is very important to ensure validity and reliability of the test results obtained by the IVD devices.
These programs are essential in confirming the delivery of patient diagnostic outcomes, which are reliable and without errors, such as misdiagnosis because of device-related errors, which can impact the health of the patient.Request a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/in-vitro-diagnostics-ivd-quality-control-marketThe regulation of these In vitro diagnostics devices are controlled by the respective regulatory bodies, which includes the U.S. FDA (Food and Drug Administration), the International Medical Device Regulators Forum (IMDRF), the European Commission, the Australian Therapeutic Goods Administration (TGA), the Eurasian Economic Union (EEU) and the Brazilian National Health Surveillance Agency (ANVISA).The currently undergoing, extensive R related activities beside the introduction of new laws with the aim of improving the efficacy and safety levels of the IVD services are anticipated to drive market growth.
For example, in September 2012, a new regulation for IVD devices was published by the European Commission targeted to enhance the transparency, safety and the traceability without constraining innovation.
In 2016, QC market was one of the largest segments because of the rapidly developing IVD technologies and the existence of numerous internal QC programs for the different features of the IVD device-based procedures of testingApplication InsightsThere are numerous applications of the IVDs, which includes haematology, immunology, coagulation, clinical chemistry, molecular diagnostics and microbiology.
The home care market segment is anticipated to observe a lucrative progression owing to the persistent increase in the usage devices for point-of-care testing.
This analysis of the Global In-Vitro Diagnostics (IVD) Quality Control Market aims to offer relevant and well-researched insights into the contemporary market scenario and the emergent growth dynamics.
The report on In-Vitro Diagnostics (IVD) Quality Control Market also gives the market players and fresh contenders a holistic view of the global market landscape.
The comprehensive study will help both established and emerging players formulate lucrative business strategies and realize their short-term and long-term goals.The In-Vitro Diagnostics (IVD) Quality Control industry has witnessed a stable growth rate in the past decade and is expected to continue on the same path in the forthcoming decades.
Therefore, it is crucial to recognize all investment opportunities, potential market threats, restraining factors, challenges, market dynamics, and technological development to intensify footholds in the In-Vitro Diagnostics (IVD) Quality Control sector.
This report has evaluated all the above mentioned aspects to present a detailed assessment to the reader to assist them in achieving the desired growth in their businesses.Fill in your details to get your hands on an Exclusive Sample of this Report @ https://www.reportsanddata.com/sample-enquiry-form/1508Companies profiled for this market studyAgilent Diagnostics, Abbott Diagnostics, Becton, Dickson and Company, Bio-Rad Laboratories, Inc., and ThermoFisher ScientificFor the purpose of the study, this Reports and Data has segmented the Global In-Vitro Diagnostics (IVD) Quality Control Market on the basis of product type, manufacturer type, design, application, end user and the regional outlook:Product Type (Revenue, USD Million; 2016–2026)Quality ControlsWhole Blood-based ControlsSerum-based ControlsPlasma-based ControlsUrine-based ControlsOther IVD Quality ControlsData Management SolutionsQuality Assurance ServicesManufacturer Type (Revenue, USD Million; 2016–2026)Instrument Manufacturer ControlsIndependent Manufacturer ControlsThird-party ControlsInstrument Specific Manufacturer ControlsApplication (Revenue, USD Million; 2016–2026)Clinical ChemistryImmunochemistryHaematologyMolecular DiagnosticsCoagulation/HaemostasisMicrobiologyOthersEnd User (Revenue, USD Million; 2016–2026)HospitalsClinical LaboratoriesHome CareOthersClick here to Get customization & check available discount for the report @ https://www.reportsanddata.com/discount-enquiry-form/1508Table of Contents:Study Coverage: It includes key manufacturers covered, key market segments, the scope of products offered in the global In-Vitro Diagnostics (IVD) Quality Control market, duration considered, and objectives of the research.
Additionally, it segments the market on the basis of product type and application.Executive Summary: It offers a summary of other key studies, annual growth rate, competitive landscape, driving factors, market trends and issues, and macroscopic indicators.Production by Region: Here, the report delivers information related to import and export, production, revenue, and key players of all regional markets inspected in the report.Profile of Manufacturers: Each firm profiled in this segment is investigated by means of SWOT analysis, available products, global production, value, capacity, and other crucial factors.Highlights the following key factors:1) Business description-Detailed description of a firm’s operations and business segments.2) Corporate strategy – Analyst’s summarization of the company’s business strategy.3) SWOT Analysis – A detailed analysis of the company’s strengths, weaknesses, opportunities, and challenges.4) Company history – A company’s evolution, highlighting its key events through the years.5) Major products and services – A list of flagship products, services, and brands of the company.6) Key competitors – A list of key competitors of the company.7) Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.8) Detailed financial ratios for the past five years – The latest financial ratios derived from annual financial statements released by the company in the last five years.Browse the comprehensive TOC and data tables @ https://www.reportsanddata.com/report-detail/in-vitro-diagnostics-ivd-quality-control-marketThe growth of this market across the globe is dependent on multiple factors; including consumer base of several In-Vitro Diagnostics (IVD) Quality Control products, inorganic growth models adopted by companies, price volatility of feedstocks, and product innovation, along with their economic prospects in both producer and consumer nations.Overall, this report provides a clear view of every vital factor of the market without the need to refer to any other research reports or data sources.
Global In-Vitro Diagnostics (IVD) Quality Control Market Forecast to 2028 encompasses crucial data about the global In-Vitro Diagnostics (IVD) Quality Control market and includes a thorough examination of technological development, market drivers, market share, market size, and regional segmentation.
The report also provides a comprehensive evaluation of the market trends, vital statistical data, accurate market estimations, and the key suppliers and manufacturers of the In-Vitro Diagnostics (IVD) Quality Control market.The report is also attuned with the currently ongoing COVID-19 pandemic and its effect on the key segments of the market.
The report is updated with the impact of COVID-19 crisis, economic landscape, and present and future impact of COVID-19 on the market.
The report also aims to benefit the user by providing constructive data to gain insight into the market growth, size, and investment approaches.The key companies profiled in the market are: Abbott Laboratories Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Siemens Healthineers, Randox Laboratories Ltd., Technopath Clinical Diagnostics, Fortress Diagnostics, Roche Diagnostics, Bio-Techne Corporation, Danaher Corporation, SeraCare Life Sciences Inc.The report also covers a comprehensive analysis of the strategic alliances such as mergers and acquisitions, joint ventures, partnerships, collaborations, agreements, government and corporate deals, and product launches and brand promotions.
The report also offers a thorough analysis of the product portfolios, production capacity, gross margins, revenues, and costing of the key manufacturers and vendors.
Furthermore, it also covers SWOT analysis and Porter’s Five Forces Analysis to offer a deeper insight into the competitive landscape of the market.By Product & Service Type (Revenue, USD Million; 2018-2028)Quality Control ProductsWhole Blood-based ControlsSerum/Plasma-based ControlsUrine-based ControlsData Management SolutionsQuality Assurance ServicesSource-based IVD Quality ControlsBy Manufacturer (Revenue, USD Million; 2018-2028)Third-Party Control ManufacturersOriginal Equipment Manufacturers (OEMs)Instrument-Specific ControlsIndependent ControlsBy Application (Revenue, USD Million; 2018-2028)Immunochemistry/ImmunoassayCoagulation & HemostasisMolecular DiagnosticsClinical ChemistryMicrobiologyHematologyOthersBy End-user (Revenue, USD Million; 2018-2028)HospitalsHome CareClinical LaboratoriesAcademic & Research InstitutesContract Research Organizations (CROs)IVD ManufacturersOthersBrowse Complete Report “In-Vitro Diagnostics (IVD) Quality Control Market” @ https://www.reportsanddata.com/report-detail/in-vitro-diagnostics-ivd-quality-control-marketThe report further segments the market on the basis of key regions of the world and offers an assessment of the production and manufacturing capacity, import and export, production and consumption patterns, supply and demand ratio, and the presence of key players in each region.
The rising number of certified clinical laboratories requires quality control (QC) services to maintain their standards, associated with the increasing acceptance of third party providers of quality control services, to ensure the accurate and reproducible test results, and better outcomes which is anticipated to drive the growth.
Request a Sample PDF Copy of This Report @ https://www.millioninsights.com/industry-reports/in-vitro-diagnostics-ivd-quality-control-market/request-sample The key driving factors responsible for the growth of In Vitro Diagnostics (IVD) Quality Control market : For the establishment of definite standards of quality, the internal Quality Control (QC) programs and the external QAS (Quality Assurance Schemes) is very important to ensure validity and reliability of the test results obtained by the IVD devices.
These programs are essential in confirming the delivery of patient diagnostic outcomes, which are reliable and without errors, such as misdiagnosis because of device-related errors, which can impact the health of the patient.
The regulation of these In vitro diagnostics devices are controlled by the respective regulatory bodies, which includes the U.S. FDA (Food and Drug Administration), the International Medical Device Regulators Forum (IMDRF), the European Commission, the Australian Therapeutic Goods Administration (TGA), the Eurasian Economic Union (EEU) and the Brazilian National Health Surveillance Agency (ANVISA).
The currently undergoing, extensive R related activities beside the introduction of new laws with the aim of improving the efficacy and safety levels of the IVD services are anticipated to drive market growth.
For example, in September 2012, a new regulation for IVD devices was published by the European Commission targeted to enhance the transparency, safety and the traceability without constraining innovation.